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Abstract
Purpose: The purpose of this study is to give an overview of studies investigating the role of fludeoxyglucose
F18 (18F-FDG) positron emission tomography (PET) scanning in patients with aortic aneurysms with a focus on
molecular characteristics of the aneurysm wall.
Methods: MEDLINE, EMBASE, and the Cochrane database were searched for relevant articles. After inclusion and
exclusion, we selected 18 relevant articles reporting on 18F-FDG PET scanning of aortic aneurysms.
Results: The sample size of studies is limited, and there are no standardized imaging protocols and quantification
methods. 18F-FDG PET scanning was shown to display molecular characteristics of the aortic wall. Different studies
showed contradictory findings of aortic 18F-FDG uptake in aneurysm patients compared to controls.
Conclusions: Non-invasively determining molecular characteristics of aortic wall weakening might lead to better
rupture and growth prediction. This might influence the decision of the surgeon between conservative and surgical
treatment of aneurysms. To date, there is conflicted evidence regarding the use of 18F-FDG PET scanning to predict
aneurysm rupture and growth. The role of 18F-FDG PET scanning in rupture risk prediction needs to be further
investigated, and standardized imaging protocols and quantification methods need to be implemented.
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Introduction
Abdominal aortic aneurysm (AAA) is an abnormal focal
dilation of the aortic wall and the most accepted definition
for it is a diameter of 3.0 cm or more. Ruptured AAA is a
serious complication with an overall mortality rate of 90 %,
making it essential to develop strategies to predict rupture.
Currently, the decision between conservative versus surgi-
cal treatment involves weighing the risk of aneurysm
rupture versus the risks of a surgical procedure. This calcu-
lation of aneurysm rupture risk is based on assumptions of
population-averaged properties for the aneurysm wall based
on maximum aneurysm diameter. Anatomic characteristics
like aortic tortuosity and diameter asymmetry have also
been described as reflectors for rupture risk [1]. However,
not only large aneurysms but also small aneurysms can
rupture, making the diameter of AAA alone not the ideal
determinant in risk stratification [2, 3].
The etiology of AAA is multifactorial including genetic
factors. AAA rupture represents a mechanical failure [4],
attributable to alterations in extracellular matrix compo-
nents of the aortic wall. Increased activity of the so-called
matrix metalloproteinases, enzymes with proteolytic activity
that also play a role in other degenerative diseases like
osteoarthritis, has been demonstrated [5–8]. Production of
these enzymes by inflammatory cells such as macrophages,
B- and T-lymphocytes, and mast cells has been shown
[6, 9]. Fludeoxyglucose F18 (18F-FDG) is a positron emission
tomography (PET) tracer, which is believed to reflect glucose
accumulation by inflammatory cells, and thus, it could be
useful in non-invasively displaying inflammatory characteris-
tics of the aneurysm wall. It would be of great importance,
both from the patient’s perspective and as from a health-
care economical point of view, to predict aneurysm rupture
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by non-invasively detecting inflammatory activity in the
aortic aneurismal wall. We therefore conducted a systematic
review of human studies in which 18F-FDG PET scanning is
performed on patients with aortic aneurysms and correl-
ation between 18F-FDG PET scanning and clinical events or
histology/molecular characteristics is addressed.
Methods
Search strategy
MEDLINE and EMBASE databases were systematically
searched on all studies relating abdominal or thoracic
aortic aneurysm, 18F-FDG PET scanning, and surgically
derived aortic wall material (Fig. 1). The search was con-
ducted in September 2015 according to the search strat-
egy and data collection guidelines of the Preferred
Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) statement [10]. A manual search of
the Cochrane Library yielded no relevant articles.
Data collection and extraction
After disregarding duplicates, the title and the abstract of
271 articles were independently screened by two observers
Fig. 1 Flowchart of the systematic review
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(U.T. and D.M) according to predefined criteria. The search
query can be found in Additional file 1. Inclusion criteria
were as follows: (1) presenting data about patients with
thoracic or abdominal aortic aneurysm and (2) 18F-FDG
PET scanning with or without reporting data on correlation
between 18F-FDG PET scanning and molecular characteris-
tics. Letters, comments, abstracts for conferences, case re-
ports <10, and animal studies were eliminated. We
excluded studies with acute aortic syndromes, as these are
generally considered as a separate pathology.
Nineteen articles of studies that matched the inclusion
criteria were obtained. Articles were excluded if one of
the following criteria were applicable: (1) ex vivo im-
aging and (2) not written in English. After reading the
full text of the articles, we excluded one article because
of not focusing on PET of the aortic wall. Reference lists
of the included articles were searched manually and
yielded no new articles. Disagreements between the re-
viewers were resolved by consensus.
Results
Our search resulted in 18 articles in which 18F-FDG PET
scanning is reported on patients with aortic aneurysms.
PET scanning protocols were specified in all studies. QPCR,
histology, and immunohistochemistry protocols were de-
scribed in all studies. PET scanning was either performed in
asymptomatic patients or in symptomatic patients, which is
in some studies defined by abdominal or lower back pain
and in other studies by accelerated growth, leaking, or rup-
ture of the aneurysm. An overview of AAA patients investi-
gated with 18F-FDG PET scanning is given in Table 1.
Articles correlating 18F-FDG uptake in AAA patients to
clinical events
In 2002, Sakalihasan et al. were the first to report the
correlation of 18F-FDG uptake in AAA patients to clin-
ical events. In this study, 26 patients with AAA were
included and visual uptake of 18F-FDG was seen in ten
patients [11]. Patients with asymptomatic AAA but also
Table 1 An overview of studies in patients with AAAs which are investigated with 18F-FDG PET scanning










Correlation of PET uptake with
Sakalihasan et al. [11] 26 72 63 60 Visual Growth, symptoms, leaking and rupture
Reeps et al. [14] 12 69 59 90 SUVmax AAA disease, symptoms, histopathologic
characteristics of aneurysm wall instability
Truijers et al. [13] 17 71 40 60 SUVmax AAA disease
Kotze et al. [20] 14 73.6 54 180 (SUVmax) –
Menezes et al. [27] 17 74 53 45, 60, 120, 180 TBR (SUVmax) –
Kotze et al. [22] 25 75 50 180 TBR (SUVmax) Inverse correlation between baseline FDG
uptake and future aneurysm expansion
Muzaffar et al. [28] 15 74 50 60 SUVmax –
Marini et al. [17] 12 73 48 60–90 TBR (SUVmax) Lower FDG uptake in AAA patients compared
to controls
Palombo et al. [16] 40 74 49 ≥60 Visual, TBR
(SUVmax)
Lower FDG uptake in AAA patients compared
to controls
Tegler et al. [15] 12 65 58 60 SUVmax, –
Reeps et al. [24] 18 71 56 90 SUVmax,
SUVmean
Symptoms, histopathologic characteristics of
aneurysm wall instability
Courtois et al. [25] 8 PET+ 78 54.5 60 TBR (SUVmax) Growth, symptoms, histopathologic characteristics
of aneurysm wall instability
10 PET− 75 58.5 60 –
Courtois et al. [26] 6 PET+ 79 54.5 60 TBR (SUVmax) Histopathologic characteristics of aneurysm wall
6 PET− 72 56.5 60
Kotze et al. [23] 40 75 48.5 180 TBR (SUVmax) Negative correlation with aneurysm expansion
Nchimi et al. [12] 53 (6 TAA) 72 41.7 54–100 TBR (SUVmax) Future clinical events, wall stress
Barwick et al. [19] 151 74 50 90 TBR (SUVmax) Lower SUVmax in AAA patients compared to
controls
Morbelli et al. [18] 30 74.6 49 90 TBR (SUVmax) Lower FDG uptake in AAA patients compared to
controls
Morel et al. [21] 39 71 46 90 TBR (SUVmax) Inverse correlation between baseline FDG uptake
and future aneurysm expansion
TBR = Target to Background Ratio
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patients presenting with lower back pain and AAA
(symptomatic AAA) were analyzed. While patients with
negative 18F-FDG uptake required no urgent surgery,
five of the ten patients with positive uptake required
urgent surgery within 2 to 30 days. However, not all
symptomatic AAAs showed 18F-FDG uptake. Next to
the study performed by Sakalihasan et al., another study
correlated 18F-FDG uptake to clinical events in AAA
patients. Nchimi et al. studied 53 patients with aortic
aneurysms, of which 6 are with thoracic aortic aneu-
rysms [12]. More clinical events (rupture, dissection, or
growth >1 cm) occurred in patients with visually in-
creased 18F-FDG uptake. Quantitatively, 18F-FDG posi-
tron emission tomographic uptake correlated positively
with both wall stress and stress/strength index.
Articles comparing 18F-FDG uptake between AAA patients
and controls without AAA disease
Findings published by Sakalihasan et al. in 2002
prompted further research to investigate the role of 18F-
FDG PET scanning in rupture risk prediction. Several
studies have been performed in which 18F-FDG uptake
of AAA patients is compared to 18F-FDG uptake in con-
trols without AAA disease. In a study published in 2008
by Truijers et al., 17 patients with asymptomatic AAA were
investigated retrospectively and maximum standardized up-
take values (SUVmax) were compared to age-matched con-
trols. 18F-FDG PET scanning in both the patient and
control groups was performed for staging of primary lung
cancer [13]. Patients had significantly higher SUVmax values
than controls. Accordingly, Reeps et al. report increased
SUVmax values in 12 patients with asymptomatic AAA
compared to an age-matched control group without
aortic aneurysm disease [14]. In 2012, Tegler et al. [15]
examined seven asymptomatic men with large AAA
(range, 52–66 mm) and five asymptomatic men with
small AAA (range 34–40 mm) with 18F-FDG PET scan-
ning. Consistent with the findings of Truijers et al. and
Reeps et al., a significant increase in SUVmax was found
in asymptomatic patients with AAAs compared to con-
trols without aneurysm [14].
Nonetheless, studies have been published reporting no
difference or even decreased 18F-FDG uptake in AAA
patients compared to controls without AAA disease. In
a case-control study conducted in 2012, Palombo et al.
compared 18F-FDG uptake in aortic walls of 40 male pa-
tients with asymptomatic AAA disease to controls (with
neoplastic disease) without any clinical evidence for ath-
erosclerotic disease [16]. Patients with AAAs both had
lower mean SUV and maximum SUV compared to adja-
cent non-aneurysmal segments within the same patient
but also compared to controls. Consistent with the find-
ings of Palombo et al. [16], another study published by
Marini et al. in the same year reports decreased SUVmax
in the aneurismal walls of 12 patients with asymptomatic
AAA, compared to 12 age- and sex-matched controls
(with neoplastic disease) [17]. Morbelli et al. confirmed
findings of Palombo et al. [16] and Marini et al. [17]. In
this study, 18F-FDG uptake in 30 AAA patients was
compared to 30 controls. Decreased 18F-FDG uptake
was seen in the aneurysms of AAA patients in compari-
son to the corresponding arterial segment of the
control group but also in comparison to the non-
aneurysmal segment of the same patient [18]. Another
case-control study is published by Barwick et al. in
2014 [19]. They searched a PET/CT database of pre-
dominantly oncological patients and matched 151
aneurysm patients to 159 non-aneurysmal controls and
do not report significant differences in visual 18F-FDG
uptake or SUVmax between patients and controls.
Moreover, no significant differences were found in
SUVmax between patients who underwent surgery, had
AAA rupture, or did not have rupture or surgery.
Articles correlating 18F-FDG uptake to aneurysm expansion
Since AAA has an inflammatory component, increased
inflammatory activity in the aortic wall could poten-
tially indicate recent growth of an aneurysm and thus
help in rupture risk prediction. Two studies investi-
gated the correlation between 18F-FDG uptake and re-
cent AAA growth [14, 20], yet no correlations were
found. In addition, 18F-FDG uptake in the aortic aneur-
ismal walls may indicate future aneurysm expansion.
Three studies investigated the relationship between
18F-FDG uptake and future expansion [21-23]. Kotze
et al. investigated 18F-FDG uptake in 25 AAA patients
with small aortic abdominal aneurysms and measured
aneurysm expansion rate 6 months and 1 year later
with ultrasound. Of the 25 patients included, three pa-
tients had lower back or abdominal pain. A significant
inverse correlation was found between whole-vessel
SUVmax and ultrasound expansion at 1 year after scan-
ning [22]. This research group again reported the same
findings in 40 AAA patients, of which 2 presented with
lower back pain [20]. SUVmax again correlated inversely
with further aortic expansion at 1 year measured by
ultrasound.
Recently, an article reported about the potential of
18F-FDG in risk stratification of AAA [21]. In this
study, patients with AAA <55 mm underwent 18F-FDG
PET scanning at baseline and 9 months later. Patients
with an increase in AAA size after 9 months had sig-
nificantly lower 18F-FDG uptake at baseline compared
to patients without significant increase in AAA size.
Moreover, the increase in 18F-FDG uptake throughout
time was higher in patients displaying a significant in-
crease in AAA size.
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Correlation of 18F-FDG uptake to histology of the aortic
wall in AAA
The ability of 18F-FDG PET scanning to non-invasively
detect histopathological characteristics of the aneurismal
wall was investigated in six studies (Table 1).
Reeps et al. [14] studied 12 asymptomatic and 3 patients
presenting with aneurysm-specific abdominal pain: symp-
tomatic AAA. All patients underwent 18F-FDG PET/CT,
followed by open AAA repair. Analysis by immunohistol-
ogy was done from areas with maximum 18F-FDG uptake.
Immunohistological analysis showed that increasing SUV-
max levels were significantly associated with increasing
medial inflammatory cell infiltrates, higher densities of
CD68-positive macrophages, and with CD3-positive T-
lymphocytes. Moreover, increased 18F-FDG uptake was
significantly associated with increased MMP-9 expression.
Furthermore, significant negative correlation of collagen
fiber and vascular smooth muscle cells (VSMC) content
compared with increasing SUVmax was found. Five years
later, the same research group also investigated the role of
partial volume correction in accurate quantitative assess-
ment of 18F-FDG uptake in the same patient group [24].
Partial volume corrected mean SUV (PVC-SUVmean) and
maximum SUV (PVC-SUVmax) were determined. Both
PVC-SUVmean and PVC-SUVmax were significantly higher
than the uncorrected SUVmean and SUVmax. Previously
demonstrated significance correlation of 18F-FDG uptake
with macrophage infiltration and increased MMP-9
expression did not change by applying partial volume cor-
rection nor improved correlation coefficients.
In 2012, Tegler et al. [15] investigated seven patients
with large AAAs (size 52–66 mm) and five patients with
small AAAs (size 30–40 mm). No visual uptake of 18F-
FDG was seen, while histological analysis of specimens
taken from the aneurismal wall of the seven patients with
large AAAs all showed high inflammatory cell infiltration
with B-lymphocytes, T-lymphocytes, and macrophages.
Marini et al. report a decrease in cell density in
aneurysmal wall biopsies of AAA patients. They con-
cluded that, because a significant relation was found be-
tween cell density and 18F-FDG uptake, reduced cell
density in these patients account for the low prevalence of
positive findings of AAA patients at PET imaging [17].
In a study published in 2013 by Courtois et al. [25],
PET/CT imaging in 18 patients with symptomatic or
asymptomatic AAA was performed. Eight of the patients
showed 18F-FDG uptake (PET+), while ten showed no
18F-FDG uptake (PET−). A comparison was made in
immunohistology, mRNA, and protein levels of PET+
and PET− patients. Moreover, biopsies of the AAA wall
in regions with maximum 18F-FDG uptake were also
compared to biopsies in the same patient where no up-
take of 18F-FDG was seen. No significant correlation was
found between AAA diameter and 18F-FDG uptake.
Significantly higher levels of circulating C-reactive pro-
tein (CRP) were found preoperative in PET+ patients.
Inflammatory infiltrate in the adventitia was significantly
higher in the PET+ group compared to the PET− group
or the biopsy taken from the negative site. The density
of smooth muscle cells in the media was significantly re-
duced in the positive 18F-FDG uptake sites as compared
with their respective negative counterparts and with the
PET− patients. The mRNA and protein levels of extracel-
lular matrix degrading enzymes (MMPs) in the media but
also adventitia significantly increased in 18F-FDG positive
sites, compared to negative sites in the same patients.
A similar approach was used again by the same re-
search group very recently, in which 12 AAA patients
were included, with six of the patients showing 18F-FDG
uptake and six showing no uptake. Regions with 18F-
FDG uptake showed increased gene expression levels of
markers involved in inflammatory processes and extra-
cellular matrix remodeling. Moreover, increased levels of
a chemokine, CCL18, were found in the adventitia of pa-
tients with 18F-FDG uptake [26].
Articles reporting solely PET scanning in AAA patients
without correlations
Some studies solely investigated 18F-FDG PET scanning
without correlating it to clinical events, aneurismal
growth, or histological characteristics. In a study, per-
formed in 2009 by Kotze et al., 14 patients with AAA
were investigated of which one presented with lower
back pain [20]. Twelve of these patients showed in-
creased 18F-FDG uptake, defined by this group by a
SUVmax >2.5 but not correlations were made.
Menezes et al. examined 17 patients with asymptom-
atic AAA and performed PET scans at several time
points after 18F-FDG injection [27]. They conclude that
there is no significant advantage in imaging 3 h over 1 h
after 18F-FDG injection. In this study, no correlation of
PET scanning to clinical characteristics is reported. In
2011, Muzaffar et al. reviewed 18F-FDG PET/CT scans
from 926 patients with cancer and found AAA in 15 pa-
tients [28]. This study solely reports a SUVmax, without
correlating it to clinical characteristics.
Discussion
In this article, we give an overview of what is known
about 18F-FDG PET scanning in patients with aortic an-
eurysms. Only one study reports inclusion of patients
with thoracic aneurysms [12]. Imaging modalities as
MRI and CT scanning were excluded, because an earlier
search yielded no useful articles to discuss in this review.
18F-FDG PET scanning is an evolving imaging tool in
the evaluation of inflammatory disorders and might thus
be useful in predicting rupture risk. Indeed, Xu et al.
[29] showed that high wall stress regions, calculated
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using the finite element method, colocalize with areas of
positive 18F-FDG uptake. These results are consistent
with the findings of Nchimi et al. [12].
Contradictory reports on 18F-FDG uptake in AAA pa-
tients compared to controls can be found in this review.
Patient selection is a possible explanation for these con-
tradictions. For instance, Sakalihasan et al. scanned
large, rapidly expanding or symptomatic AAAs [11]. In
addition, some studies scanned patients prior to surgery
[14–17, 25, 26], while other studies analyzed 18F-FDG
PET scans of AAA patients under routine surveillance,
either prospectively [12, 21–23] or retrospectively
[13, 19]. Furthermore, studies investigated both pa-
tients and controls with a neoplastic disease [13, 19],
but studies also report on 18F-FDG PET scanning in
AAA patients without neoplastic disease and compare
this to a control group with neoplastic disease [16, 17].
As neoplasms display increased 18F-FDG uptake, this
might lead to false positive readings. Moreover, two
studies did not specify the reason of 18F-FDG PET
scanning in their control group [14, 15].
18F-FDG uptake in AAA patients should be compared
to a control group without atherosclerosis: patients with-
out hypertension, hyperlipidemia, and non-smokers.
Atherosclerosis is a systemic disease, and results in the con-
trol group might be influenced by calcification. While sev-
eral studies described their control group [13, 16, 17, 19],
others did not [14, 15]. Currently, not much is known
about calcification and 18F-FDG uptake. There are some
reports in the literature suggesting that 18F-FDG uptake
precedes calcification [30, 31]. A study reported congruent
18F-FDG uptake with calcification spots on CT in 7 % of
calcifications [32], while there is also a study reporting 18F-
FDG uptake in the thoracic aortic wall, distinct from calcifi-
cation sites at CT [33]. Rominger et al. retrospectively eval-
uated 932 patients with 18F-FDG PET/CT and show
significant correlation between 18F-FDG uptake and calcifi-
cations in the abdominal aorta [34]. Moreover, increased
18F-FDG uptake and increased calcifications in the arterial
system were both established as independent predictors for
future vascular events, while both increased 18F-FDG up-
take and calcification were identified as being at the highest
risk for a vascular event. Four studies in this review investi-
gated whether there was a difference in calcification be-
tween AAA patients and controls. While Kotze et al. [20]
and Marini et al. [17] find no significant differences,
Palombo et al. [16] and Morbelli et al. [18] report increased
arterial calcium load in AAA patients compared to con-
trols. Moreover, an inverse correlation between arterial cal-
cium load and arterial wall metabolism was found.
In addition to patient selection, and incorrect control
groups, timing of PET imaging and quantification
methods is a possible explanation to contradictory reports
in literature. Considerable differences exist in timing of
imaging and quantification methodology as reported in
studies. Only seven studies specified whether visual uptake
of 18F-FDG was seen [11, 12, 15, 16, 19, 25, 26]. Some
studies describe the use of SUVmax or SUVmean divided by
blood pool or liver activity [12, 16–19, 21–23, 25–27],
while others only use SUVmax or SUVmean without blood
pool correction [13–15, 20, 24, 28]. This makes it difficult
to compare results in literature, highlighting the import-
ance of standardized techniques and quantification
methods. Six studies scanned 60 min after 18F-FDG injec-
tion [11–13, 15, 25, 26, 28], four other studies 90 min [14,
18, 21, 24], and three others [20, 22, 23] 180 min after 18F-
FDG administration. Blomberg et al. showed improve-
ment in atherosclerotic plaque quantification in the ca-
rotid arteries and thoracic aorta scanning 180 min after
18F-FDG administration compared to 90 min [35]. How-
ever, Menezes et al. [21] show that there is no significant
difference in SUVmax uptake at 60 min compared to scan-
ning at 180 min.
Correlations between 18F-FDG uptake and patho-
logical weakening of the wall can aid in investigating
how effective this imaging tool will be in rupture predic-
tion. Correlation between 18F-FDG PET and histology
was first shown in a case report [36], where 18F-FDG up-
take corresponded to an inflammatory infiltrate in the aor-
tic wall. In this review, several studies show correlation
between 18F-FDG uptake and histological aneurysm charac-
teristics. Reeps et al. [14] showed that there is a significant
correlation between total inflammatory infiltrate and
MMP-9. MMP-9 already has been shown to be significantly
upregulated in ruptured sites of AAAs compared to non-
ruptured sites [37]. Moreover, its expression is shown to be
decreased in non-ruptured abdominal aneurysms com-
pared to ruptured abdominal aneurysms [38]. It remains
the question whether the inflammatory infiltrate in the
AAA wall is an etiological factor responsible for the
increase in MMP or merely a reaction to an unknown etio-
logical factor causing this increase in MMP expression.
Remarkably, Truijers et al. [13], showed the highest
18F-FDG uptake in patients with relatively small AAAs,
while the patient with the largest AAA showed very low
18F-FDG uptake. Moreover, studies that compared 18F-
FDG uptake in AAA compared to a matched control
group reported lower 18F-FDG uptake [16–18]. These
observations are most likely the result of a reduction in
cell density occurring in large AAAs as documented by
Marini et al. [17]. In contrast to the aneurysmal seg-
ment, the arterial tree of patients with AAA display
higher 18F-FDG uptake [18]. The dispersed nature of in-
flammatory cell islands in larger AAAs causes an under-
estimation of radioactivity concentration whenever the
thickness of the source is less than twice the system spatial
resolution. PET scanning has limited spatial resolution,
and therefore, it remains a challenge to investigate the
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arterial wall. While findings of Marini et al. do not label
18F-FDG PET scanning as an inadequate tool for risk
stratification in AAA, it is essential to realize that cur-
rently, a patient with a negative PET scan should not be
considered as low risk for rupture.
Courtois et al. [25, 26] compared patients with and
without 18F-FDG uptake as assessed visually. Interesting
results are shown that give insight into the pathophysi-
ology of abdominal aortic aneurysms. The significant re-
duction in expression of MMP-12 and MMP-15 from
regions with no 18F-FDG uptake in PET+ patients may
be indicative of a final attempt in the tissue to restore
extracellular matrix. This response might be a futile at-
tempt to protect from a yet unknown etiologic factor,
leading to more inflammation and thus to a PET+ pa-
tient. However, when analyzing remodeling of ECM, it is
important to take into account substrates of proteolytic
enzymes [39] and the contribution of the structural pro-
tein to tensile strength of the aortic wall.
In humans, 18F-FDG is the most frequently used PET
tracer in nuclear investigations of aortic aneurysms and
was also shown to have the highest sensitivity in a rat
experimental AAA model, compared to two other PET
tracers involved in leukocyte activation [40]. Tegler et al.
investigated two other PET tracers targeting proteins in-
volved in chronic inflammation but were not able to
show differences in uptake between AAA patients and
controls [41].
Developing effective PET tracers to improve AAA rup-
ture risk stratification should focus on pathophysio-
logical processes in AAA. As AAA walls display a large
infiltration of immune cells such as macrophages, PET
tracers targeting receptors on macrophages such as in-
tegrin αvβ3 might be useful [42]. The search for novel
PET tracers that can be useful in predicting AAA rup-
ture is ongoing. Animal studies are helpful in investigat-
ing novel molecular probes that might be useful in
predicting AAA rupture. English et al. used a novel ab-
dominal aortic aneurysm model in rats and showed that
increased 18F-FDG uptake is predictive of rupture [43].
Nahrendorf et al. [44] show, by using macrophage-
targeted nanoparticles labeled with fluorine-18 in PET/CT
scanning, that macrophages localized in the aneurysmal
wall can be visualized. Recently, Shi et al. showed angio-
genesis in AAA experimental mice by PET scanning with
a (64)Cu-labeled anti-CD105 antibody [45]. Also, other
imaging techniques are being used for rupture prediction
in animal models such as non-invasive MR imaging and
near-infrared fluorescence [46, 47]. Future experiments
need to prove the ability to use these techniques for rup-
ture risk stratification in AAA patients.
In addition to the aneurysmal wall, improved molecular
imaging of the intraluminal thrombus (ILT) not only
qualitatively but also quantitatively might provide valuable
information helpful in predicting rupture risk. Koole et al.
[48] showed that ILT thickness is associated with higher
MMP levels and lower vascular smooth cell numbers,
which might implicate that AAA wall adjacent to a thick
layer of ILT is significantly weaker than wall in the same
AAA adjacent to a thinner or no ILT. Moreover, Nchimi
et al. showed that the occurrence of ILT precedes AAA
peak growth [49].
Symptoms in AAA patients point out to an increased
rupture risk, but these indicators of increased risk for
AAA rupture are not available in asymptomatic AAA
patients. In this patient group, there is a need to establish
risk percentages for AAA rupture. Studies report subtle
differences in 18F-FDG uptake between patients and con-
trols [14, 15, 18, 50]. As definition of quantitative cutoff
values is essential in establishing risk percentages for
aneurysm rupture and keeping this little difference in
SUVmax in mind between AAA patients and controls, it is
essential to correct for partial volume effects observed in
the thin aortic wall [24]. However, in the end, it is unlikely
that one single PET scan with a random PET tracer will
lead to a reliable single quantitative cutoff value for rup-
ture risk prediction. Serial imaging of AAAs will increase
the chance to detect inflammatory activity in the aortic
aneurismal wall. Investigating the aneurysm wall metabol-
ism at more than a single time point will give valuable
information as formation and expansion of aortic aneu-
rysms takes many years. It is currently unknown whether
inflammatory processes lead to expansion of aneurysms.
No significant correlation was found between the degree of
18F-FDG uptake and recent AAA growth rate or maximum
infrarenal AAA diameter in four studies [13, 14, 16, 22].
This supports the hypothesis that inflammation precedes
expansion instead of expansion preceding inflammation.
However, in contradiction with this hypothesis, Kotze et al.
report inverse correlation between whole-vessel 18F-FDG
uptake and aneurysm expansion at ultrasound after 1 year,
indicating that aortic aneurysms with lower metabolic ac-
tivity may be more likely to expand [22]. AAA formation
and progression is a dynamic process, with repetitive se-
quences of inflammatory damage and repair. Periods of
rapid expansion are followed by periods of quiescence [51].
It is likely that this dynamic process causes a cyclic vari-
ation in 18F-FDG uptake. Indeed, findings published by
Morel et al. support evidence of cyclic changes in the me-
tabolism of AAA during growth phases [21]. Consistent
with findings published by Kotze et al. [22], AAAs with
lower 18F-FDG uptake were more likely to expand in this
study. It is likely that aneurysms with lower 18F-FDG are at
the end of their “period of stasis” and will start with their
“period of expansion.” Next to the study published by
Morel et al. [21], solely one case study reports a correlation
between aneurysm wall glucose metabolism and inflamma-
tory changes with an increase in SUVmax and aneurysm size
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over time [52]. Following AAA patients with repeated
PET/CT scans might be useful, but this approach needs to
be weighed against higher radiation exposure.
Conclusions
Currently, a limited number of studies have investigated
the role of 18F-FDG PET scanning in patients with
AAAs and the correlation between 18F-FDG PET scan-
ning of AAAs and molecular characteristics (Table 2).
Therefore, we included also studies without molecular
characteristics available. While there are studies show-
ing increased 18F-FDG uptake in patients with AAAs
correlated with clinical events, there are also studies
reporting decreased 18F-FDG uptake in AAA patients
compared to controls. Literature suggests that 18F-FDG
PET scanning might be useful in displaying molecular
alterations characteristic of the weakening of the AAA
wall. However, it still remains a question whether these
molecular characteristics of aortic wall weakening
might lead to better rupture and growth prediction.
Moreover, most studies are limited by a very small
patient population. Larger patient populations are war-
ranted. Standardized imaging protocols and quantification
methods are essential to compare patient populations.
However, given the conflicting evidence to date with
18F-FDG PET scanning, it is unlikely that a reliable
quantitative cutoff value to predict rupture risk may be
established. The potential of change in quantitative
measure on serial 18F-FDG PET scanning may be help-
ful. Moreover, animal studies in which non-invasively
detection of inflammation or proteolysis in AAA wall
by means of in vivo molecular imaging is investigated
and needs to be implemented in humans in order to
improve rupture risk stratification.
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